中 EN

Promote a healthier life
for humankind through
advancements in science

Science-based

Benefit the patients with
high-quality medication as
we determined to innovate

Innovation-driven

Build a leading global
biopharmaceutical group
to serve more

Going Global

Fulfill social responsibilities
through accountable actions

Embrace Social
Responsibilities

Explore who we are

About us

Innovation is the core of our development strategy

Partnering

We are actively looking for synergistic partnerships

Walk into Hengrui

Est.

1970

Marketed Innovative Products in China

15

Partnered Innovative Product Launched

2

SH 600276

Est.

1970

Marketed Innovative Products in China

8

Partnered Innovative Product Launched

1

SH 600276

Pipeline

Our innovative pipeline covers the most of major therapeutic areas and continues to grow

Pipeline

Our innovative pipeline covers the most of major therapeutic areas and continues to grow

Investor

Enhance communication between our company and investors

Media

Hengrui Pharma Partners with Merck to Advance Innovative Cancer Therapies

Media

Jiangsu Hengrui Pharma and Elevar Therapeutics Announce Global Commercialization Licensing Agreement for PD-1 Inhibitor Camrelizumab in Combination with Rivoceranib for uHCC

Media

Hengrui Pharma Announces Positive Data of Two ADC Programs at the AACR Annual Meeting 2023

Privacy Notice Cookies Notice

苏公网安备 32070402010095号

苏ICP备11027260号-13互联网资格证书:(苏)-非经营性-2023-0040

苏公网安备 32070402010095号

金年会|金年会·jinnian(金字招牌)诚信至上

Promote a healthier life for humankind through advancements in science

Science-based

Benefit the patients with high-quality medication as we determined to innovate

Innovation-driven

Build a leading global biopharmaceutical group to serve more

Going Global

Fulfill social responsibilities through accountable actions

Embrace SocialResponsibilities

Explore who we are

Innovation is the core of our development strategy

We are actively looking for synergistic partnerships

Walk into Hengrui

Est.

1970

Marketed Innovative Products in China

15

Partnered Innovative Product Launched

2

SH 600276

Est.

1970

Marketed Innovative Products in China

8

Partnered Innovative Product Launched

1

SH 600276

Our innovative pipeline covers the most of major therapeutic areas and continues to grow

Our innovative pipeline covers the most of major therapeutic areas and continues to grow

Enhance communication between our company and investors

Hengrui Pharma Partners with Merck to Advance Innovative Cancer Therapies

Jiangsu Hengrui Pharma and Elevar Therapeutics Announce Global Commercialization Licensing Agreement for PD-1 Inhibitor Camrelizumab in Combination with Rivoceranib for uHCC

Hengrui Pharma Announces Positive Data of Two ADC Programs at the AACR Annual Meeting 2023

Promote a healthier life
for humankind through
advancements in science

Benefit the patients with
high-quality medication as
we determined to innovate

Build a leading global
biopharmaceutical group
to serve more

Fulfill social responsibilities
through accountable actions

Embrace Social
Responsibilities